Trademark: 98130997
Word
COVLA
Status
Pending
Status Code
686
Status Date
Tuesday, April 16, 2024
Serial Number
98130997
Mark Type
4
Filing Date
Monday, August 14, 2023
Published for Opposition
Tuesday, April 16, 2024

Trademark Owner History
TEVA PHARMACEUTICALS USA, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Trademark Events
Sep 12, 2023
New Application Office Supplied Data Entered
Aug 17, 2023
New Application Entered
Mar 12, 2024
Approved For Pub - Principal Register
Mar 27, 2024
Notification Of Notice Of Publication E-Mailed
Apr 16, 2024
Published For Opposition
Apr 16, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 4, 2024
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24